Scopus BioPharma Inc. Quarterly Liabilities, Current in USD from Q4 2019 to Q2 2023

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Scopus BioPharma Inc. quarterly Liabilities, Current history and growth rate from Q4 2019 to Q2 2023.
Scopus BioPharma Inc. Liabilities, Current for the quarter ending June 30, 2023 was $11M.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2023	$11M			Jun 30, 2023	10-Q	2023-08-11
Q1 2023	$9.31M			Mar 31, 2023	10-Q	2023-05-12
Q4 2022	$7.45M	+$3.28M	+78.8%	Dec 31, 2022	10-Q	2023-08-11
Q4 2021	$4.17M	+$365K	+9.59%	Dec 31, 2021	10-K	2023-04-14
Q3 2021	$2.24M	-$1.55M	-41%	Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$8.79M			Jun 30, 2021	10-Q	2021-08-13
Q1 2021	$4.48M			Mar 31, 2021	10-Q	2021-05-17
Q4 2020	$3.81M	+$2.95M	+345%	Dec 31, 2020	10-K	2022-04-15
Q3 2020	$3.79M			Sep 30, 2020	10-Q/A	2021-02-26
Q4 2019	$855K			Dec 31, 2019	10-K	2021-03-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.